Delve faces new allegations that it violated the open source license of its customer, Sim.ai, by taking the customers's tool and passing it off as its own.

Delve Bio, a UCSF spin-out and pioneer in metagenomic next-generation sequencing (mNGS) for infectious diseases, announced data underscoring the clinical impact of mNGS using Delve Detect to identify ...

Shortly after Delve's founder published a lengthy denial of allegations, while promising changes, the accuser came forward with more alleged details.

On March 18, an anonymous Substack account named Deepdelver published a lengthy article that claimed to have evidence that ...

Delve cofounder and CEO Karun Kaushik has responded publicly to fraud allegations against the AI compliance startup, a move ...

Compliance company says whistleblower claims of fabricated security certifications are the work of “a malicious actor.” ...

The controversy surrounding compliance startup Delve escalated rapidly over the past two weeks. Here’s a look at how the ...

Explore the implications of the Delve controversy on AI compliance practices. Discover insights and best practices for trust ...

Karun Kaushik, the Indian-origin co-founder and CEO of Delve, addressed the controversy surrounding the compliance startup in ...

Delve and Y Combinator have parted ways. The YC startup with two Indian-origin techies at the helm has been embroiled in ...